TSHA - Taysha Gene Therapies Inc.

Healthcare - Sector

TSHA is currently covered by 9 analysts with average potential upside of $19.73 (285.76%) backed by 1 price targets and 22 ratings. Analyst's average stock valuation to be materialised ratio is 5.56% with an average time for price targets to be met of 15.33 days.

Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN on 09-Nov-2022.

Highest price target for TSHA is 26, Lowest price target is 2, average price target is 14.

Best performing analysts who are covering TSHA - Taysha Gene Therapies Inc.:

Salveen Richter Silvan Tuerkcan Laura Chico Gbola Amusa Gil Blum Geulah Livshits

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

3

$0.81 (36.99%)

20 days ago

1/3 (33.33%)

$7.81 (52.75%)

92

Buy

18

$16.11 (852.38%)

1 months 4 days ago

0/1 (0%)

$15.02 (504.03%)

Buy

5

$2.81 (128.31%)

31

3 months 17 days ago

0/2 (0%)

$3.95 (25.53%)

Buy

32

$29.7 (1291.30%)

3 months 17 days ago

0/1 (0%)

$27.9 (680.49%)

Buy

36

$33.81 (1543.84%)

44

7 months 28 days ago

0/6 (0%)

$27.03 (294.59%)

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login